Skip to main content
Fig. 6 | Cancer Imaging

Fig. 6

From: How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology

Fig. 6

FDG-PET (a) performed for follow-up of a patient with a germline succinate dehydrogenase subunit B mutation and a known left glomus jugulare paraganglioma (arrowhead) demonstrates a new area of FDG-avidity just below the skull base on the right (arrow). The subsequent post-contrast MRI (b) supports that this is a new paraganglioma rather than a metastasis

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us